Allarity Therapeutics and FivepHusion Collaborate to Support Clinical Development of Deflexifol with DRP Companion Diagnostics
Portfolio Pulse from Benzinga Newsdesk
Allarity Therapeutics, Inc. (NASDAQ:ALLR) and FivepHusion have entered into a Clinical Collaboration Agreement. Under this agreement, Allarity will support FivepHusion's future clinical development of Deflexifol™ for the treatment of solid tumors by using certain of Allarity's drug-specific DRP® companion diagnostics.
July 31, 2023 | 10:02 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The collaboration with FivepHusion could potentially enhance Allarity's position in the market by expanding the use of its DRP® companion diagnostics.
The collaboration with FivepHusion could potentially enhance Allarity's position in the market by expanding the use of its DRP® companion diagnostics. This could lead to increased revenues and profitability for Allarity in the future.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100